MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-13-2026
FONAR Corporation DSO Ratio 2011-2026 | FONR
Annual DSO Ratio FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 237 | 221 | 200 | 189 | 170 | 164 | 157 | 200 | 106 | 114 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 237 | 106 | 176 |
Quarterly DSO Ratio FONAR Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.7 | 17.1 | 13.4 | 13.3 | 13.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | 35.2 | 3.37 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.9 | 24.9 | 26.9 | 25.7 | 23 | 25.4 | 46.6 | 48 | 48.4 | 47.6 | 46.6 | 47.3 | 51.5 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.37 K | 11.9 | 198 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
LivaNova PLC
LIVN
|
53.8 | $ 62.73 | -0.81 % | $ 3.42 B |  Britain |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Medtronic PLC
MDT
|
68.8 | $ 86.97 | -0.28 % | $ 112 B | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.37 | 1.48 % | $ 22.1 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
34.4 | $ 5.59 | -7.91 % | $ 64.4 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 32.65 | 2.83 % | $ 1.5 B | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 36.74 | 0.3 % | $ 1.14 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
60 | $ 11.8 | -0.59 % | $ 467 M |  Curacao |
 |
Electromed
ELMD
|
137 | $ 24.81 | 1.29 % | $ 210 M | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.72 | 7.39 % | $ 39.2 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Penumbra
PEN
|
46.5 | $ 334.7 | -0.27 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 11.59 | 11.76 % | $ 1.57 B | USA |
 |
Myomo
MYO
|
35.3 | $ 0.7 | -1.85 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
40.7 | $ 226.67 | -0.18 % | $ 15.9 B | USA |
 |
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.88 | 4.02 % | $ 145 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 15.96 | -3.1 % | $ 374 M | USA |
 |
Outset Medical
OM
|
97.7 | $ 3.59 | -0.69 % | $ 54.6 K | USA |
 |
Quanterix Corporation
QTRX
|
81.6 | $ 3.86 | -2.03 % | $ 165 M | USA |
 |
Inspire Medical Systems
INSP
|
42.6 | $ 51.94 | -0.52 % | $ 1.53 B | USA |
 |
Pulmonx Corporation
LUNG
|
50.8 | $ 1.33 | -4.68 % | $ 54.1 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
67 | $ 2.59 | 1.57 % | $ 7.18 M | USA |
 |
InspireMD
NSPR
|
76 | $ 1.79 | 2.59 % | $ 115 M | Israel |
 |
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
70.4 | - | - | $ 2.07 B | USA |